MXCT vs SBAC · rev $38.6M vs P/E 30, rev $693.7M
MaxCyte Inc (MXCT) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported SBAC revenue for 2024-12-31 was $693.7M. Net income was $748.7M. Revenue was up 3.9% from 2024-09-30 to 2024-12-31. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
MXCT currently screens at market cap $124.3M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the MXCT and SBAC stock pages for the full models.
Not investment advice.